Cite
APA Citation
Rinke, A., Neary, M. P., Eriksson, J., Hunger, M., Doan, T., Karli, D., & Arnold, R. (n.d.). 1311PDHealth-related quality of life (HRQoL) for octreotide long-acting (oct l-a) vs. placebo (PBO) in patients (pts) with metastatic midgut neuroendocrine tumors (mmNETs) in the phase IIIb PROMID trial. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095493491.0x000034